Cape Town, South Africa — December 1 st , 2025 — Immobazyme , a South African platform biotechnology company building scalable, cost-effective biologics, has secured an additional R25 million in funding, bringing its total capital raised to R50 million. The round was led by the University Technology Fund (UTF II), with participation from Fireball Capital and University of Stellenbosch Enterprises (USE) as co-investors. The new capital will accelerate the expansion of Immobazyme’s...

The Growth Factor | Newsletter | April 2025 April Updates We were in high demand this month, with our team attending a range of exciting...

The Growth Factor | Newsletter | March 30th 2025 Ayanda Hlophe, Chemical Engineer, working in her lab. What’s happening in the labs?...